| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 11017274 | European Journal of Cancer | 2018 | 7 Pages |
Abstract
This is the first study to demonstrate the clinical significance of baseline hypoalbuminaemia and hyponatraemia, which are predictors of development of other EAs in phase I patients. Grade III/IVÂ EAs are adverse prognostic factors of OS independent of serum albumin levels.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Alvaro H. Ingles Garces, Joo Ern Ang, Malaka Ameratunga, Maxime Chénard-Poirier, David Dolling, Nikolaos Diamantis, Satyanarayana Seeramreddi, Raghav Sundar, Johann de Bono, Juanita Lopez, Udai Banerji,